
|Articles|June 6, 2018
What every urologist needs to know about SpaceOAR® hydrogel
Advertisement
Study data has shown that SpaceOAR® hydrogel significantly improves quality of life for patients with prostate cancer who have undergone radiotherapy. But what does it take to implement this procedure into routine practice, and what can urologists expect regarding reimbursement?
In this supplement, practicing urologists will share perspectives on this procedure, addressing topics that include:
Advertorial Supported by:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Neil Baum, MD, and Abraham Morgentaler, MD, discuss the history of testosterone and prostate cancer
2
Published data show rPFS benefit with lutetium Lu 177 vipivotide tetraxetan in mHSPC
3
Elizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab
4
Optimizing care for men with overactive bladder, with Keith Xavier, MD
5








